"10.1371_journal.pone.0040087","plos one","2012-06-29T00:00:00Z","Marisol Chang; Tom Alsaigh; Erik B Kistler; Geert W Schmid-Schönbein","Department of Bioengineering, University of California San Diego La Jolla, California, United States of America; Department of Anesthesiology and Critical Care, University of California San Diego Medical Center, San Diego, California, United States of America; Institute of Engineering in Medicine, University of California San Diego, La Jolla, California, United States of America","Conceived and designed the experiments: MC EBK GWSS. Performed the experiments: MC TA. Analyzed the data: MC GWSS. Contributed reagents/materials/analysis tools: EBK GWSS. Wrote the paper: MC TA EBK GWSS.","Dr. Schmid-Schönbein is scientific consultant to Leading Ventures, San Diego, California, United States of America. Dr. Schmid-Schönbein owns stocks in “Inflammagen”. The other authors have declared that no competing interests exist. There is a patent application by UC San Diego on some aspects of the treatment used in this work,there are no products in development or marketed products to declare. This does not alter the authors adherence to all the PLoS ONE policies on sharing data and materials.","2012","06","Marisol Chang","MC",4,FALSE,3,2,2,4,TRUE,TRUE,FALSE,0,NA,FALSE
